Grant: Project Grant - PA: MSK, Skin and Oral Health: Clinical Research - MSK Health
Research Institute of the McGill University Health Centre
$100,000.00
Impact of Internet Delivered Cognitive Behavioral Therapy for Insomnia in Persons with Systemic Lupus Erythematosus: A Randomized Clinical Trial
FY 2018-19
Summary
Sleep disturbances, including difficulty falling asleep, staying asleep, and/or waking up early in the morning are all symptoms of insomnia, reported in up to 80% of persons with lupus. Importantly, sleep disturbances worsen other symptoms including fatigue, pain, and depression, all of which remain poorly managed in lupus and continue to compromise patient quality of life. For the majority of patients, insomnia goes unrecognized and untreated. Cognitive behavioural therapy for insomnia (CBTi) is considered first-line treatment for insomnia, yet no study to date has evaluated this intervention in lupus patients. The proposed study will determine whether internet delivered CBTi (ICBTi) will reduce insomnia and other commonly experienced symptoms in lupus, including fatigue, depression and pain compared to a treatment as usual control group. We expect that the lupus patients assigned to the CBTi group will report greater improvements in insomnia and other related symptoms, compared to the control group after completing the 6-week program and that these improvements will be maintained at 6-months following completion of the program. To inform the future use ICBTi as part routine lupus care for sleep management, a secondary aim of this study will be to examine patient characteristics such as sociodemographics (age, income level) and symptom severity at study entry (e.g. severity of insomnia, fatigue, pain, depression) associated with greater improvements in insomnia as a result of the 6-week program. This study fills an important gap in lupus care and will provide new knowledge on the benefits of a nondrug intervention for managing insomnia in lupus. If found to be beneficial, CBTi delivered over the internet will help overcome barriers that currently prevent appropriate treatment of insomnia in lupus care, which in turn will result in better management of sleep and associated clinical symptoms, improvements in quality of life and ultimately reduced healthcare costs.
Department
Program
Project Grant - PA: MSK, Skin and Oral Health: Clinical Research - MSK Health
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
394851
Name
Da Costa Deborah M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Psychosocial, Sociocultural & Behavioural Determinants of Health
Projecttitle
Impact of Internet Delivered Cognitive Behavioral Therapy for Insomnia in Persons with Systemic Lupus Erythematosus: A Randomized Clinical Trial
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: MSK, Skin and Oral Health: Clinical Research - MSK Health
Keyworddelim
Internet Intervention; Lupus; Rct; Sleep Disturbances
Abstract
Sleep disturbances, including difficulty falling asleep, staying asleep, and/or waking up early in the morning are all symptoms of insomnia, reported in up to 80% of persons with lupus. Importantly, sleep disturbances worsen other symptoms including fatigue, pain, and depression, all of which remain poorly managed in lupus and continue to compromise patient quality of life. For the majority of patients, insomnia goes unrecognized and untreated. Cognitive behavioural therapy for insomnia (CBTi) is considered first-line treatment for insomnia, yet no study to date has evaluated this intervention in lupus patients. The proposed study will determine whether internet delivered CBTi (ICBTi) will reduce insomnia and other commonly experienced symptoms in lupus, including fatigue, depression and pain compared to a treatment as usual control group. We expect that the lupus patients assigned to the CBTi group will report greater improvements in insomnia and other related symptoms, compared to the control group after completing the 6-week program and that these improvements will be maintained at 6-months following completion of the program. To inform the future use ICBTi as part routine lupus care for sleep management, a secondary aim of this study will be to examine patient characteristics such as sociodemographics (age, income level) and symptom severity at study entry (e.g. severity of insomnia, fatigue, pain, depression) associated with greater improvements in insomnia as a result of the 6-week program. This study fills an important gap in lupus care and will provide new knowledge on the benefits of a nondrug intervention for managing insomnia in lupus. If found to be beneficial, CBTi delivered over the internet will help overcome barriers that currently prevent appropriate treatment of insomnia in lupus care, which in turn will result in better management of sleep and associated clinical symptoms, improvements in quality of life and ultimately reduced healthcare costs.
Competitiondate
201809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Da Costa, Deborah M; Fortin, Paul R; Savard, Josée
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~